Cargando…

Use of Convalescent/ Post-Vaccination Plasma in Immunosuppressed Patients with Persistent Sars-Cov-2 Infection

Detalles Bibliográficos
Autores principales: Pedraza, Alexandra, Charry, Paola, Fornells, Jordi, De Pablo-Miró, Mar, Guardia, Ares, Guinetti, Katia, Marin, Dagmar, Sanchez, Alba, Ferrer, Aura, Sauleda, Silvia, Martinez, Nuria, Sanz, Cristina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society of Hematology. Published by Elsevier Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9665181/
http://dx.doi.org/10.1182/blood-2022-167120
_version_ 1784831233037959168
author Pedraza, Alexandra
Charry, Paola
Fornells, Jordi
De Pablo-Miró, Mar
Guardia, Ares
Guinetti, Katia
Marin, Dagmar
Sanchez, Alba
Ferrer, Aura
Sauleda, Silvia
Martinez, Nuria
Sanz, Cristina
author_facet Pedraza, Alexandra
Charry, Paola
Fornells, Jordi
De Pablo-Miró, Mar
Guardia, Ares
Guinetti, Katia
Marin, Dagmar
Sanchez, Alba
Ferrer, Aura
Sauleda, Silvia
Martinez, Nuria
Sanz, Cristina
author_sort Pedraza, Alexandra
collection PubMed
description
format Online
Article
Text
id pubmed-9665181
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher The American Society of Hematology. Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-96651812022-11-16 Use of Convalescent/ Post-Vaccination Plasma in Immunosuppressed Patients with Persistent Sars-Cov-2 Infection Pedraza, Alexandra Charry, Paola Fornells, Jordi De Pablo-Miró, Mar Guardia, Ares Guinetti, Katia Marin, Dagmar Sanchez, Alba Ferrer, Aura Sauleda, Silvia Martinez, Nuria Sanz, Cristina Blood Online Publication Only The American Society of Hematology. Published by Elsevier Inc. 2022-11-15 2022-11-15 /pmc/articles/PMC9665181/ http://dx.doi.org/10.1182/blood-2022-167120 Text en Copyright © 2022 The American Society of Hematology. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Online Publication Only
Pedraza, Alexandra
Charry, Paola
Fornells, Jordi
De Pablo-Miró, Mar
Guardia, Ares
Guinetti, Katia
Marin, Dagmar
Sanchez, Alba
Ferrer, Aura
Sauleda, Silvia
Martinez, Nuria
Sanz, Cristina
Use of Convalescent/ Post-Vaccination Plasma in Immunosuppressed Patients with Persistent Sars-Cov-2 Infection
title Use of Convalescent/ Post-Vaccination Plasma in Immunosuppressed Patients with Persistent Sars-Cov-2 Infection
title_full Use of Convalescent/ Post-Vaccination Plasma in Immunosuppressed Patients with Persistent Sars-Cov-2 Infection
title_fullStr Use of Convalescent/ Post-Vaccination Plasma in Immunosuppressed Patients with Persistent Sars-Cov-2 Infection
title_full_unstemmed Use of Convalescent/ Post-Vaccination Plasma in Immunosuppressed Patients with Persistent Sars-Cov-2 Infection
title_short Use of Convalescent/ Post-Vaccination Plasma in Immunosuppressed Patients with Persistent Sars-Cov-2 Infection
title_sort use of convalescent/ post-vaccination plasma in immunosuppressed patients with persistent sars-cov-2 infection
topic Online Publication Only
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9665181/
http://dx.doi.org/10.1182/blood-2022-167120
work_keys_str_mv AT pedrazaalexandra useofconvalescentpostvaccinationplasmainimmunosuppressedpatientswithpersistentsarscov2infection
AT charrypaola useofconvalescentpostvaccinationplasmainimmunosuppressedpatientswithpersistentsarscov2infection
AT fornellsjordi useofconvalescentpostvaccinationplasmainimmunosuppressedpatientswithpersistentsarscov2infection
AT depablomiromar useofconvalescentpostvaccinationplasmainimmunosuppressedpatientswithpersistentsarscov2infection
AT guardiaares useofconvalescentpostvaccinationplasmainimmunosuppressedpatientswithpersistentsarscov2infection
AT guinettikatia useofconvalescentpostvaccinationplasmainimmunosuppressedpatientswithpersistentsarscov2infection
AT marindagmar useofconvalescentpostvaccinationplasmainimmunosuppressedpatientswithpersistentsarscov2infection
AT sanchezalba useofconvalescentpostvaccinationplasmainimmunosuppressedpatientswithpersistentsarscov2infection
AT ferreraura useofconvalescentpostvaccinationplasmainimmunosuppressedpatientswithpersistentsarscov2infection
AT sauledasilvia useofconvalescentpostvaccinationplasmainimmunosuppressedpatientswithpersistentsarscov2infection
AT martineznuria useofconvalescentpostvaccinationplasmainimmunosuppressedpatientswithpersistentsarscov2infection
AT sanzcristina useofconvalescentpostvaccinationplasmainimmunosuppressedpatientswithpersistentsarscov2infection